News

Spinal cord injury is one of the leading causes of long-term disability worldwide, often impacting young people who face a ...
A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized ...
Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure ...
Idiopathic normal-pressure hydrocephalus is a neurologic disorder characterized by impaired gait, balance, cognition, and ...
A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized ...
Acupuncture needling is a safe and effective treatment option for older adults with chronic lower back pain, according to a September study published in the Journal of the American Medical Association ...
Many of the randomized controlled trials for large vessel vasculitis with significant or nonsignificant outcomes show fragility, and measures do not vary with the risk for bias, drug type, or subtype.
Results of a new study support using semaglutide and tirzepatide to reduce risk in patients with cardiometabolic heart ...
Secondary analysis of Women’s Health Initiative data finds no elevated atherosclerotic cardiovascular risk in hormone therapy ...
Tripling the weekly dose of semaglutide (Ozempic, Wegovy) resulted in greater weight loss compared with placebo in adults with obesity, both with and without type 2 diabetes, but did not increase the ...
Celltrion, Inc. today showcased its longstanding commitment to expanding its biosimilar portfolio in the field of ...
According to ESC, these recommendations respond directly to a request from the European Commission to provide expert advice ...